FORWARD PHARMA A/S's ticker is FWP and the CUSIP is 34986J105. A total of 13 filers reported holding FORWARD PHARMA A/S in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | -50.0% | 1,100 | -60.3% | 0.00% | – |
| Q4 2018 | $2,000 | – | 2,774 | +3979.4% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 68 | -99.8% | 0.00% | – |
| Q2 2018 | $105,000 | -24.5% | 38,662 | -40.0% | 0.00% | – |
| Q1 2018 | $139,000 | -69.5% | 64,443 | -48.0% | 0.00% | – |
| Q4 2017 | $456,000 | -33.5% | 123,982 | +9.7% | 0.00% | – |
| Q3 2017 | $686,000 | +184.6% | 113,054 | +908.2% | 0.00% | – |
| Q1 2017 | $241,000 | +760.7% | 11,213 | +627.2% | 0.00% | – |
| Q2 2016 | $28,000 | +460.0% | 1,542 | +394.2% | 0.00% | – |
| Q1 2016 | $5,000 | -97.8% | 312 | -97.4% | 0.00% | – |
| Q4 2015 | $224,000 | +11100.0% | 11,833 | +9599.2% | 0.00% | – |
| Q3 2015 | $2,000 | -97.4% | 122 | -94.0% | 0.00% | – |
| Q2 2015 | $77,000 | -78.7% | 2,042 | -88.3% | 0.00% | – |
| Q4 2014 | $362,000 | – | 17,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 100,000 | $2,356,000 | 16.27% |
| BVF INC/IL | 1,016,324 | $23,945,000 | 4.84% |
| Baupost Group | 5,367,300 | $126,454,000 | 2.11% |
| Cormorant Asset Management, LP | 335,068 | $7,894,000 | 1.26% |
| EcoR1 Capital, LLC | 101,995 | $2,403,000 | 1.09% |
| HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 157,397 | $3,708,000 | 0.92% |
| Assured Investment Management LLC | 1,102,924 | $25,985,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 135,000 | $3,181,000 | 0.41% |
| CLOUGH CAPITAL PARTNERS L P | 260,300 | $6,133,000 | 0.26% |
| Orbimed Advisors | 960,600 | $22,632,000 | 0.23% |